Want to join the conversation?
$TRV 2Q15 Call: Segment operating income: Business and International $543MM; net written premiums down by over 1% from 2Q14. Bond & Specialty $151MM; net written premiums were flat to 2014. Personal Insurance $174MM; underlying combined ratio improved by more than 1 point from 2Q14.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.